Retatrutide – 20 mg (Triple-Agonist Metabolic Peptide)

Retatrutide – 20 mg (Triple-Agonist Metabolic Peptide)
Disponible para reserva
Avg Duration: 7 weeks
Titration Needed: Yes
Cycle Length: Ongoing, once-weekly treatment
Retatrutide is a next-generation triple-agonist peptide targeting the GLP-1, GIP, and glucagon receptors—a powerful combination designed to dramatically improve appetite control, metabolic rate, and fat oxidation. Studies show significantly greater weight-loss potential compared to traditional single-pathway GLP-1 therapies.
Perfect for individuals seeking stronger metabolic acceleration, improved energy regulation, and enhanced appetite control through an advanced, multi-pathway mechanism.
💧 What’s included?
-
1 vial containing 20 mg of lyophilized Retatrutide
-
1 vial with 3 ml of sterile water for reconstitution
🔑 Key Benefits
✅ Triple-pathway activation (GLP-1 + GIP + glucagon)
✅ Strong appetite suppression and craving control
✅ Supports increased metabolic rate and fat oxidation
✅ Helps stabilize insulin response
⏳ How Long Does One Vial Last?
Duration depends on dosing:
-
Those following traditional dosing schedule – 7 weeks
⭐ Ideal For
-
Users seeking more aggressive metabolic results
-
People who haven’t responded strongly to GLP-1 alone
-
Individuals with high appetite levels or insulin resistance
-
Advanced weight-loss protocols
-
Clinics offering next-generation peptide therapy